Skip to content

The effect of Eryngium Billardieri plant and aerobic exercise in diabetes

The effect of consumption of hydro-alcoholic extract of Eryngium Billardieri with aerobic exercise on blood level and lipid profile in type 2 diabetic patients

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211116053081N2
Enrollment
45
Registered
2022-10-16
Start date
2022-10-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Receiving 100 mg capsules of eryngium billardieri twice a day in the morning and in the evening and aerobic exercises for six weeks, 5 days a week, 60 minutes every day with an avera

Sponsors

Raja University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age range 35 to 60 Suffering from type 2 diabetes Having fasting blood sugar between 150 and 200 mg/dL Using metformin and sulfonylurea group drugs (Glibenglamid, gliclazide, etc.) to control blood sugar Following the diet given by the nutritionist Not using any medicinal plants other than Eryngium Billardieri during the research

Exclusion criteria

Exclusion criteria: Having regular physical activity (more than two sessions per week) during the last six months Inability to perform aerobic exercises due to physical diseases such as atherosclerosis, orthopedic problems, etc. Having diseases other than diabetes such as blood pressure, cardiovascular diseases and thyroid diseases

Design outcomes

Primary

MeasureTime frame
Blood glucose. Timepoint: The beginning and the sixth week of study. Method of measurement: Serum blood (ELISA).;Lipid profile. Timepoint: The beginning and the sixth week of study. Method of measurement: Autoanalyzer method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Shiri Shahsavar

Qazvin University of Medical Sciences

Mr.shiri@qums.ac.ir+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026